Slashdot Log In
Celera Opens Up DNA Database
Posted by
timothy
on Sat Apr 30, 2005 08:23 PM
from the time-to-meet-the-ceo dept.
from the time-to-meet-the-ceo dept.
greenplato writes "Thirty billion base pairs from the sequences of humans, mice, and rats that were available only by subscription to Celera's DNA database are being put into the public domain. Celera will donate this information to a 'federally run database,' presumably GenBank. Francis Collins, head of the National Human Genome Research Institute, notes that 'data just wants to be public.' Stories in BusinessWeek and The New York Times."
This discussion has been archived.
No new comments can be posted.
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
Full
Abbreviated
Hidden
Loading... please wait.
Shouldn't that be (Score:5, Insightful)
Re:Shouldn't that be (Score:2, Funny)
Re:Shouldn't that be (Score:3, Funny)
Okay, it's probably just me but when I read that I had a vision of Brent Spiner rattling the bars of a cage yelling "Picard, get your bald ass down here, Data want to be free!"
Re:Shouldn't that be (Score:2)
(On the flip-side, this is excellent news. Researchers have a long history of putting things in the public domain - they have been the main driving force behind the idea - and it is most excellent that commercial researchers are beginning to realize that this isn't purely by chance.)
from the summary (Score:5, Funny)
Data hates when you anthropomorphize it.
Re:from the summary (Score:2)
I thought he wanted to be human!?
Re:from the summary (Score:3, Funny)
I don't think it wants to be free. (Score:3, Insightful)
Re:I don't think it wants to be free. (Score:4, Interesting)
Considering the millions of dollars that Celera invested in gene sequencing, it should at least have the opportunity to make back that money.
If he were creating something new then perhaps, but it was just a land grab. The DNA was there and they tried to patent as much of it as possible. It reminds me of the Eddie Izzard skit when the Europeans claim America and the Indians say, "but it's here, you know, we're using it, how can it be yours?" And the Europeans say, "but ah, have you got a flag?"
Replace flag with patent. You might as well say that the Spaniards spent a lot of money colonizing Peru so they deserved all the gold. This is DNA! It belongs to no individual or corporation. I want access to my source code for whatever purposes I choose.
Parent
Oh No! (Score:5, Funny)
Re:Oh No! (Score:2)
Gnu's
Not
Urkel.
What about patents? (Score:3, Insightful)
Re:What about patents? (Score:3, Informative)
In a word, no.
You can't generally patent "found" sequences. You have to create or assemble something novel. The raw sequence of the human genome is not patentable. Inserting novel or transgenic genes into the human genome might be, but that's still science fiction.
Re:What about patents? (Score:5, Insightful)
I wish that were not the case. However, there are many gene patents in existence. The trick is that now you have to show a function for that gene - although bioinformatics is sophisticated (or rather, automated) enough that you can come up with a plausible-sounding function without ever doing benchwork.
What's really being patented is the medical application of these sequences. For instance, Company X discovers that gene Y is overexpressed in cancer Z. They take out a patent on gene Y based on this discovery. That means that no one else can pursue gene Y as a therapeutic target. Moreover, in one case testing for a specific mutation to detect cancer was covered by a patent. This is a very simple piece of labwork being covered, which any competent cancer researcher could have figured out.
The end result is that patents are being awarded for hard work, not for novelty and invention. Throw enough money at a subject, and you'll get data but not necessarily results. Since companies (or academics) can now patent just the data, if someone else gets "lucky" and comes up with an actual result the patent holders can sue the tar out of them if they try to make money off it. (Or even if they don't, as in the case of the breast cancer gene; the company wanted people to pay three times as much for its own testing kit.)
You may soon be able to patent single-nucleotide polymorphisms (SNPs), which may be involved in differential drug responses. Back when I was in college we had a guest lecturer who was a biotech patent attorney, and he said he though SNPs should definitely be patentable. In any case, there is a world of difference between patenting a cancer drug, and patenting a gene (or a FUCKING POINT MUTATION) that may, in the future, be a drug target.
Since most of the human genome is noncoding, I suspect it will be harder to patent pieces of it. I also suspect that some asshole will try anyway.
Parent
Again? (Score:5, Insightful)
Re:Again? (Score:4, Insightful)
Parent
Re:Again? (Score:2)
I think that on these things, companies should be given limited access - perhaps for a few years, so that they can capitalize on their investment. After about 5 years or so, they'd better make it public domain.
Ofcourse, in that case, companies will wait for a good while before making it public that they indeed do have the data.
Re:Again? (Score:2)
Great idea, isn't it? It's called "patents", and they have thought of it a while ago. The problem is mostly with the current implementation.
Re:Again? (Score:2)
Re:Should... (Score:2)
And there WAS a public project to sequence the human genome which did rather well. If you want the data to be public then the public has to pay for it, or have some altruistic individual pay for it. Can't get something for nothing.
The parent really should keep the following in mind: if the data wasn't private then there would be no Celera data (s
Curious (Score:4, Interesting)
Re:Curious (Score:2)
Re:Curious (Score:2)
Re:Curious (Score:3, Interesting)
> unprotectable
The data itself was never protected in any way: you've always been free to read your own DNA. The database that Celera owned was protected as a trade secret. You could only look at it after signing a contract in which you agreed not to disclose what you saw.
Re:Curious (Score:2)
And under copyright. Anyone else is free to duplicate a private genome database if they're willing to spend millions of dollars on sequencing. However, you couldn't take someone else's proprietary database and redistribute it. I assume the trade secrets were any specific annotations that Celera had made - for instance, you couldn't subscribe and then start blabbing about their annotations, or re-annotating the public database based on their
Free data - or unable to sell it? (Score:5, Interesting)
I work for a biotech company with a database which we've been trying to sell subscriptions to for a few years. The prevailing experience with trying to sell the database is that people are very reluctant to shell out the cash to access the data.
I think this is a symptom of trying to sell data to academic institutions. The problems with selling to academic institutions are two-fold; Firstly the universities don't have the cold hard cash to spend on the databases, so any cost over free is too expensive. Secondly, there is the free/open culture within universities that almost punishes commercial ventures for trying to build a business around adding some kind of value to the data (such as convenience or quality of data).
Because of the lack of sales for this database, we're considering handing the data over to a large government body so that they can maintain it, because the company can't simply afford to maintain the database - it costs a lot of money to hire talented people to do database curation.
So when Celera say that "data wants to be free", I think they mean "We'd sell you this data to try and recoup our investment, but we're resigned to the fact that you're not going to buy it".
Re:Free data - or unable to sell it? (Score:5, Informative)
I would not have stated it that way. The real reason is that academics hate to leave anything unpublished. If they're constrained by copyright law or some NDA, they can't tell everyone about the fabulous new work they've been doing - or at the very least, it becomes much more difficult.
I worked in bioinformatics at a university for several years, and much of what we did was take existing databases and analyze them, then publish the results online as our own database of annotations. As part of this, we reproduced much of the original database in modified form - and all we had to do was cite the original authors and describe our methods/sources. If the databases we used had not been public, none of these projects would have happened. In some cases, we had to ignore private databases that we had limited access to because we were not allowed to reproduce any of their data.
This is only cultural to the extent that academia thrives on publications. We're not out to punish anyone from trying to make an honest buck (lots of people here collaborate with or consult for companies), but we literally can't afford, professionally, to limit ourselves in accordance with restrictions on databases. So why pay money for something we can't legally use in the manner to which we're accustomed?
Parent
...but they still own the patents to the genes? (Score:2)
Re:...but they still own the patents to the genes? (Score:2)
Finally... (Score:2, Interesting)
Some stuff you just can't sell (Score:3)
Celera saw the writing on the wall. Everyone is using the public reference assembly because it's free, and in terms of contents the two are merging toward a complete consensus as they approach total coverage. You can only make money selling this kind of information while vast portions of the genome remain unknown or unavailable, and that's not true anymore.
Plus using a different assembly than other researchers cuts you off. When we import data from dbSNP, for example, we regularly drop references to positions specified in reference to Celera contigs. (Not much of a problem, since they're in the vast minority.) The Celera assembly has not been freely downloadable and redistributable, and we haven't been including a copy of it in our software (we always include a current public assembly build). Now that this has happened, I think the next build of the public assembly is going to be really good.
The human genome project (Score:4, Interesting)
Excellent PBS video on race between government and Celera to crack the human genome:
http://www.pbs.org/wgbh/nova/genome/program.html [pbs.org]
Mirrors please..
Just don't tell Senator Santorum... (Score:2)
Oh wait, there's no corporation for him to whore himself out to. Maybe this will actually see daylight.
In case it gets slashdotted.... (Score:5, Funny)
acgcggcgatgcgtacatagctagcgctgcatagatcgactatgacgat
Re:In case it gets slashdotted.... (Score:4, Informative)
Query: 103 catcagctactatgtagctacgatc 127
Sbjct: 84163 catcagctactttgtagctacgatc 84187
The quality of match is rated at E=0.65, which means that you would expect to find a match this good by chance 65% of the time. (E value will change slightly if you search different databases.)
Try searching for the sequence yourself here under Nucleotide-nucleotide BLAST (blastn) [nih.gov]
If you want to see the real thing, you can browse one version of the "real" human genome here [nih.gov]. If you click on the blue chromosome 1, and then "Download/View Sequence/Evidence", then "display", you can see the repeating "telomere" sequence at the beginning of chromosome 1.
Parent
Does anyone remember... (Score:2, Interesting)
Well this is a bit embarrassing (Score:5, Insightful)
Anyway, Celera seems to epitomize the way large projects like this become free: they sink billions upon billions of dollars into a project which is soon supplanted by a better free (though, of course, government funded) alternative, and after years of unsuccessfully trying to sell it, release it for free for a bit of good PR.
But then again, they've made a huge contribution to the field overall; Craig Venter may be an arrogant prick, but he gets shit done, while Francis Collins mostly waxes poetic about the bright future of genomics.
Well, that seems like enough venting about the sad state of research.
30 Billion Base Pairs (Score:3, Insightful)
-Bio major/Nerd
It's already free (Score:5, Informative)
Re:'Bout Time (Score:4, Insightful)
Let's see, the one company that pioneered genome research with reliable and extremely efficient shotgun sequencing, is now an evil corporation because it wanted to use its investments in research for developing novel therapeutics. Which in the end benefits human-kind. Please...
Parent
Re:'Bout Time (Score:3, Informative)
I worked for a small biotech company that became a part of Celera. They are doing a g
Re:'Bout Time (Score:4, Insightful)
Upper management may or may not be rotten, but you don't really explain what was "evil" about their actions.
Parent
Re:'Bout Time (Score:2)
Re:'Bout Time (Score:3, Insightful)
Celera relied on the "free research" of the NIH. They extended that research with their own technique, and then patented the result of the joint data.
Re:'Bout Time (Score:2)
Fixed: Car companies rely on the "free roads" of the federal government. They extend that infrustructure with their own cars, and then profit off the result of the joint use.
How evil of them!
Re:'Bout Time (Score:2)
Re:'Bout Time (Score:2)
He just possessed it and had a "license" to it.
If anyone should hold the copyright it should be God and his parents.
Re:'Bout Time (Score:2)
Re:'Bout Time (Score:2)
Celera's advantage was/is that the data was of higher quality and their database was curated better and had a higher reliability.
Now the public databases have become good enough that you don't need to use Celera's tools. I still find that the public databases are a bit of a mess but they are good enough to get the job done.
Re:'Bout Time (Score:3, Informative)